GT Biopharma, Inc.
Clinical-stage immuno-oncology company developing therapies with its NK cell engager tech.
GTBP | US
Overview
Corporate Details
- ISIN(s):
- US36254L2097
- LEI:
- Country:
- United States of America
- Address:
- 505 MONTGOMERY STREET, 94111 SAN FRANCISCO
- Website:
- https://www.gtbiopharma.com/
Description
GT Biopharma, Inc. is a clinical-stage immuno-oncology company focused on developing innovative therapies based on its proprietary NK cell engager (TriKE®) technology. The TriKE® platform generates therapeutic agents that are designed to simultaneously bind to Natural Killer (NK) cells and cancer cells. This targeted engagement activates and directs the cytotoxic function of NK cells to selectively destroy malignant cells. The company's pipeline targets a range of hematologic malignancies and solid tumors, including acute myeloid leukemia, myeloid dysplastic syndrome, and non-Hodgkin's lymphoma.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2025-12-03 01:15 | English | 5.3 KB | |||
| 2025-12-02 23:24 |
424B3
|
English | 91.0 KB | ||
| 2025-11-26 22:30 |
8-K
|
English | 74.5 KB | ||
| 2025-11-14 22:00 |
10-Q
|
English | 1.9 MB | ||
| 2025-11-14 15:05 |
8-K
|
English | 102.9 KB | ||
| 2025-10-24 22:15 |
S-1
|
English | 234.7 KB | ||
| 2025-09-26 22:15 |
8-K
|
English | 72.6 KB | ||
| 2025-09-23 23:30 |
8-K
|
English | 79.1 KB | ||
| 2025-09-08 23:45 | English | 6.9 KB | |||
| 2025-09-08 23:45 | English | 7.4 KB | |||
| 2025-09-08 23:45 | English | 7.2 KB | |||
| 2025-09-08 23:45 | English | 7.0 KB | |||
| 2025-09-08 23:45 | English | 6.9 KB | |||
| 2025-08-29 22:15 |
8-K
|
English | 83.4 KB | ||
| 2025-08-14 22:01 |
10-Q
|
English | 2.6 MB |
Automate Your Workflow. Get a real-time feed of all GT Biopharma, Inc. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for GT Biopharma, Inc.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for GT Biopharma, Inc. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
